The Male Sexual Quotient: A Brief, Self-Administered Questionnaire to Assess Male Sexual Satisfaction
Carmita H.N. Abdo MD, PhD,
Carmita H.N. Abdo MD, PhD
Department of Psychiatry, Medical School, University of São Paulo, São Paulo, Brazil
Search for more papers by this authorCarmita H.N. Abdo MD, PhD,
Carmita H.N. Abdo MD, PhD
Department of Psychiatry, Medical School, University of São Paulo, São Paulo, Brazil
Search for more papers by this authorCarmita H.N. Abdo, MD, PhD, Rua Gil Eanes, 492 04601-041 São Paulo—SP, Brazil. Tel: 55-11-5092-5345; Fax: 55-11-5543-8338; E-mail: [email protected]
ABSTRACT
Introduction. Sexual satisfaction is an important aspect of overall life satisfaction. The Male Sexual Quotient (MSQ) was designed to provide a versatile, user-friendly instrument to measure various aspects of male sexual function and satisfaction.
Aim. Assess responses to the MSQ in men with sexual dysfunction (SD).
Methods. Items for inclusion in the MSQ were developed through interviewing 612 randomly recruited men in São Paulo, Brazil, about factors considered to influence sexual quality of life. Validation of the MSQ was conducted in two phases in men with and without SD.
Main Outcome Measure. The correlation between patients’ total MSQ score and scores on the Sexual Health Inventory for Men (SHIM).
Results. The resulting MSQ questionnaire contains 10 items that address sexual function and satisfaction and is scored on a 100-point scale, with higher scores indicating greater sexual function and satisfaction with such function. Patients’ scores on the MSQ were positively correlated with scores on the SHIM (r = 0.86; P < 0.0001). Scores on MSQ item 8, which assesses ejaculatory control, indicated that 46% of patients may have premature ejaculation (PE). The mean time for patients to complete the MSQ was 11 minutes.
Conclusions. The MSQ is a brief, comprehensive, and easily self-administered tool designed to help men identify aspects of their sexual experience that could be improved through partner dialogue, physician consultation, and appropriate treatment. MSQ scores correlated well with SHIM scores, and scores were inversely related to the severity of erectile dysfunction or PE and other male SDs. These preliminary findings suggest that the MSQ possesses good convergent validity. Nearly half of men reported problems with ejaculatory control, indicating an association between PE and other SD. Further validation of the MSQ in a double-blind trial is needed. The MSQ may aid in decision making for the treatment of SD. Abdo CHN. The Male Sexual Quotient: A brief, self-administered questionnaire to assess male sexual satisfaction. J Sex Med 2007;4:382–389.
References
- 1 Lewis RW, Fugl-Meyer KS, Bosch R, Fugl-Meyer AR, Laumann EO, Lizza E, Martin-Morales A. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004; 1: 35–9.
- 2 Moreira ED Jr, Abdo CH, Torres EB, Lobo CF, Fittipaldi JA. Prevalence and correlates of erectile dysfunction: Results of the Brazilian study of sexual behavior. Urology 2001; 58: 583–8.
- 3 Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.
- 4 Schouten BW, Bosch JL, Bernsen RM, Blanker MH, Thomas S, Bohnen AM. Incidence rates of erectile dysfunction in the Dutch general population. Effects of definition, clinical relevance and duration of follow-up in the Krimpen Study. Int J Impot Res 2005; 17: 58–62.
- 5 WHOQOL Group. Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res 1993; 2: 153–9.
- 6 Althof SE. Quality of life and erectile dysfunction. Urology 2002; 59: 803–10.
- 7 Guest JF, Das Gupta R. Health-related quality of life in a UK-based population of men with erectile dysfunction. Pharmacoeconomics 2002; 20: 109–17.
- 8 Jønler M, Moon T, Brannan W, Stone NN, Heisey D, Bruskewitz RC. The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol 1995; 75: 651–5.
- 9 Cappelleri JC, Althof SE, Siegel RL, Shpilsky A, Bell SS, Duttagupta S. Development and validation of the Self-Esteem And Relationship (SEAR) questionnaire in erectile dysfunction. Int J Impot Res 2004; 16: 30–8.
- 10 Tomlinson J, Wright D. Impact of erectile dysfunction and its subsequent treatment with sildenafil: Qualitative study. BMJ 2004; 328: 1037–9.
- 11 Symonds T, Roblin D, Hart K, Althof S. How does premature ejaculation impact a man’s life? J Sex Marital Ther 2003; 29: 361–70.
- 12 Shabsigh R, Klein LT, Seidman S, Kaplan SA, Lehrhoff BJ, Ritter JS. Increased incidence of depressive symptoms in men with erectile dysfunction. Urology 1998; 52: 848–52.
- 13 Nicolosi A, Moreira ED, Shirai M, Ismail Bin Mohd Tambi M, Glasser DB. Epidemiology of erectile dysfunction in four countries: Cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003; 61: 201–6.
- 14 Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999; 281: 537–44.
- 15 Chevret M, Jaudinot E, Sullivan K, Marrel A, De Gendre AS. Quality of sexual life and satisfaction in female partners of men with ED: Psychometric validation of the index of sexual life (ISL) questionnaire. J Sex Marital Ther 2004; 30: 141–55.
- 16 Wagner G, Fugl-Meyer KS, Fugl-Meyer AR. Impact of erectile dysfunction on quality of life: Patient and partner perspectives. Int J Impot Res 2000; 12(4 suppl): S144–6.
- 17 Araujo AB, Durante R, Feldman HA, Goldstein I, McKinley J. The relationship between depressive symptoms and male erectile dysfunction: Cross-sectional results from the Massachusetts Male Aging Study. Psychosom Med 1998; 60: 458–65.
- 18 Levinson IP. Erectile function is associated with sexual and relationship satisfaction: A pooled analysis of 26 randomized, double-blind, placebo-controlled trials. J Sex Med 2005; 2(1 suppl): 59.
- 19 Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997; 9: 141–8.
- 20 Lewis R, Bennett CJ, Borkon WD, Boykin WH, Althof SE, Stecher VJ, Siegel RL. Patient and partner satisfaction with VIAGRA (sildenafil citrate) treatment as determined by the erectile dysfunction inventory of treatment satisfaction questionnaire. Urology 2001; 57: 960–5.
- 21 Paige NM, Hays RD, Litwin MS, Rajfer J, Shapiro MF. Improvement in emotional well-being and relationships of users of sildenafil. J Urol 2001; 166: 1774–8.
- 22 Rosen RC, Seidman SN, Menza MA, Shabsigh R, Roose SP, Tseng LJ, Orazem J, Siegel RL. Quality of life, mood, and sexual function: A path analytic model of treatment effects in men with erectile dysfunction and depressive symptoms. Int J Impot Res 2004; 16: 334–40.
- 23 Dinsmore WW, Hodges M, Hargreaves C, Osterloh IH, Smith MD, Rosen RC. Sildenafil citrate (VIAGRA) in erectile dysfunction: Near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology 1999; 53: 800–5.
- 24 Giuliano F, Peña BM, Mishra A, Smith MD. Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction. Qual Life Res 2001; 10: 359–69.
- 25 Willke RJ, Yen W, Parkerson GR, Linet OI, Erder MH, Glick HA. Quality of life effects of alprostadil therapy for erectile dysfunction: Results of a trial in Europe and South Africa. Int J Impot Res 1998; 10: 239–46.
- 26 Althof SE, Turner LA, Levine SB, Risen CB, Bodner D, Kursh ED, Resnick MI. Sexual, psychological, and marital impact of self-injection of papaverine and phentolamine: A long-term prospective study. J Sex Marital Ther 1991; 17: 101–12.
- 27 McMahon CG, Samali R, Johnson H. Efficacy, safety and patient acceptance of sildenafil citrate as treatment for erectile dysfunction. J Urol 2000; 164: 1192–6.
- 28 Cappelleri JC, Bell SS, Althof SE, Siegel RS, Stecher VJ. Comparison between sildenafil-treated subjects with erectile dysfunction and control subjects on the Self-Esteem And Relationship questionnaire. J Sex Med 2006; 3: 274–82.
- 29 Williams G, Abbou CC, Amar ET, Desvaux P, Flam TA, Lycklama a Nijeholt GA, Lynch SF, Morgan RJ, Muller SC, Porst H, Pryor JP, Ryan P, Witzsch UK, Hall MM, Place VA, Spivack AP, Todd LK, Gesundheit N. The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners. MUSE Study Group. Br J Urol 1998; 82: 847–54.
- 30 Muller MJ, Benkert O. Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil. J Affect Disord 2001; 66: 255–61.
- 31 Muller MJ, Ruof J, Graf-Morgenstern M, Porst H, Benkert O. Quality of partnership in patients with erectile dysfunction after sildenafil treatment. Pharmacopsychiatry 2001; 34: 91–5.
- 32 Seidman SN, Roose SP, Menza MA, Shabsigh R, Rosen RC. Treatment of erectile dysfunction in men with depressive symptoms: Results of a placebo-controlled trial with sildenafil citrate. Am J Psychiatry 2001; 158: 1623–30.
- 33 Olsson AM, Speakman MJ, Dinsmore WW, Giuliano F, Gingell C, Maytom M, Smith MD, Osterloh I. Sildenafil citrate (Viagra®) is effective and well tolerated for treating erectile dysfunction of psychogenic or mixed aetiology. Int J Clin Pract 2000; 54: 561–6.
- 34 Montorsi F, McDermott TED, Morgan R, Olsson A, Schultz A, Kirkeby HJ, Osterloh IH. Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology 1999; 53: 1011–8.
- 35 Marks LS, Duda C, Dorey FJ, Macairan ML, Santos PB. Treatment of erectile dysfunction with sildenafil. Urology 1999; 53: 19–24.
- 36 Williams G, Abbou CC, Amar ET, Desvaux P, Flam TA, Lycklama a Nijeholt GA, Lynch SF, Morgan RJ, Muller SC, Porst H, Pryor JP, Ryan P, Witzsch UK, Hall MM, Place VA, Spivack AP, Gesundheit N. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction. MUSE Study Group. Br J Urol 1998; 81: 889–94.
- 37 Rosen RC. Measurement of male and female sexual dysfunction. Curr Psychiatry Rep 2001; 3: 182–7.
- 38 Arrington R, Cofrancesco J, Wu AW. Questionnaires to measure sexual quality of life. Qual Life Res 2004; 3: 1643–58.
- 39 Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–30.
- 40 Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–26.
- 41 Symonds T, Althof S, Rosen R, Roblin D, Layton M. Questionnaire assessment of ejaculatory control: Development and validation of a new instrument. Int J Impot Res 2002; 14(4 suppl): S33.
- 42 Althof SE, Corty EW, Levine SB, Levine F, Burnett AL, McVary K, Stecher V, Seftel AD. EDITS: Development of questionnaires for evaluating satisfaction with treatments for erectile dysfunction. Urology 1999; 53: 793–9.
- 43 Cappelleri JC, Siegel RL, Glasser DB, Osterloh IH, Rosen RC. Relationship between patient self-assessment of erectile dysfunction and the sexual health inventory for men. Clin Ther 2001; 23: 1707–19.
- 44 Abdo C. Elaboração e validação do quociente sexual —Versão masculina, uma escala para avaliar a função sexual do homem. Rev Bras Med 2006; 63: 42–6.
- 45 Wetterauer U, Grohmann W, Albrecht S. Patient satisfaction with Viagra (sildenafil citrate) for erectile dysfunction (ED) after switching from other treatment options. J Sex Med 2005; 2(1 suppl): 64–5.
- 46 Levinson IP. Viagra® (sildenafil citrate) improves erectile function and quality in men with erectile dysfunction. Presented at: 7th Congress of the European Society of Sexual Medicine; December 5–8, 2004; London, UK.
- 47 Heruti R, Ashkenazi I, Shochat T, Tekes-Manova D, Justo D. Low scores in the sexual health inventory for men questionnaire may indicate sexual disorders other than erectile dysfunction. J Sex Med 2005; 2: 181–6.
- 48 McMahon CG, Stuckey BG, Andersen M, Purvis K, Koppiker N, Haughie S, Boolell M. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2005; 2: 368–75.
- 49 McMahon CG, Abdo C, Incrocci L, Perelman M, Rowland D, Waldinger M, Xin ZC. Disorders of orgasm and ejaculation in men. J Sex Med 2004; 1: 58–65.
- 50 Byers ES, Grenier G. Premature or rapid ejaculation: Heterosexual couples’ perceptions of men’s ejacualtory behavior. Arch Sex Behav 2003; 32: 261–70.
- 51 Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346–51.
